MADURAI: Leading tertiary care multi-speciality hospital in Madurai- Hannah Joseph Hospital- which is well-known for its neuro and traumacare expertise has entered into capital markets via issuing of shares through IPO (Initial Public Offering) which opened on January 22nd 2026.
The hospital is rasing funds with this IPO and the price band is Rs.67-Rs.70 per share, the lot size being 2,000 equity shares and the IPO will close on January 27th 2026.
Dr.M.J.Arunkumar, Chairman and Managing Director of Hannah Joseph Hospital, has said that the hospital is getting into capital markets to raise funds for the proposed oncology block and to support other capacity expansion initiatives.
“Hannah Joseph Hospital in Madurai has now emerged into a multi-speciality tertiary care hospital from a single speciality focus on neurocare some years back. This IPO is expected to support our hospital’s expansion plans, for funding of capital expenditure to establish a radiation oncology centre and other medical facilities,” he said at the IPO meet in Mumbai.
The IPO size is Rs.42 crores at upper price band by fresh issue of shares and the price band is Rs.67-Rs.70 per share. The issue size is 60 lakh shares at a face value of Rs.10 each.
Dr.M.J.Arunkumar told investors and general public that Hannah Joseph Hospital in Madurai is committed to clinical excellence because it has skilled medical professionals, and it is a regional referral centre for complex neurological, neurosurgical, cardiac and traumacare.
“We have consistently strengthened our infrastructure to meet the growing needs of southern districts in Tamil Nadu. More service integration initiatives will be taken up by deploying the capital raised through IPO,” he added.
ADVERTISEMENTS:
